259 related articles for article (PubMed ID: 35956043)
1. Exosomal MicroRNA Analyses in Esophageal Squamous Cell Carcinoma Cell Lines.
Kim S; Kim GH; Park SJ; Kwon CH; I H; Lee MW; Lee BE
J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35956043
[TBL] [Abstract][Full Text] [Related]
2. Serum exosomal microRNA-766-3p expression is associated with poor prognosis of esophageal squamous cell carcinoma.
Liu S; Lin Z; Zheng Z; Rao W; Lin Y; Chen H; Xie Q; Chen Y; Hu Z
Cancer Sci; 2020 Oct; 111(10):3881-3892. PubMed ID: 32589328
[TBL] [Abstract][Full Text] [Related]
3. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.
Zhou X; Wen W; Zhu J; Huang Z; Zhang L; Zhang H; Qi LW; Shan X; Wang T; Cheng W; Zhu D; Yin Y; Chen Y; Zhu W; Shu Y; Liu P
Oncotarget; 2017 May; 8(21):34468-34480. PubMed ID: 28380431
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Derived Exosomal miR-143-3p Induces Macrophage M2 Polarization to Cause Radiation Resistance in Locally Advanced Esophageal Squamous Cell Carcinoma.
Gao LR; Zhang J; Huang N; Deng W; Ni W; Xiao Z; Liu M
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892269
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived exosomal miR-103a-2-5p facilitates esophageal squamous cell carcinoma cell proliferation and migration.
Gao DC; Hou B; Zhou D; Liu QX; Zhang K; Lu X; Zhang J; Zheng H; Dai JG
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6097-6110. PubMed ID: 32572925
[TBL] [Abstract][Full Text] [Related]
6. Exosomal circRNA FNDC3B promotes the progression of esophageal squamous cell carcinoma by sponging miR-490-5p and regulating thioredoxin reductase 1 expression.
Tang B; Zhang Q; Liu K; Huang Y
Bioengineered; 2022 May; 13(5):13829-13848. PubMed ID: 35703190
[TBL] [Abstract][Full Text] [Related]
7. Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer.
Kim DH; Park H; Choi YJ; Im K; Lee CW; Kim DS; Pack CG; Kim HY; Choi CM; Lee JC; Ji W; Rho JK
Biomark Res; 2023 Sep; 11(1):80. PubMed ID: 37705067
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression profiles and bioinformatic analysis of CAF-derived exosomal miRNAs from three moderately differentiated supraglottic LSCC patients.
Wu C; Wang M; Huang Q; Guo Y; Gong H; Hu C; Zhou L
J Clin Lab Anal; 2022 Jan; 36(1):e24108. PubMed ID: 34788477
[TBL] [Abstract][Full Text] [Related]
9. Identification of exosomal hsa-miR-483-5p as a potential biomarker for hepatocellular carcinoma via microRNA expression profiling of tumor-derived exosomes.
Lin J; Lin W; Bai Y; Liao Y; Lin Q; Chen L; Wu Y
Exp Cell Res; 2022 Aug; 417(2):113232. PubMed ID: 35659970
[TBL] [Abstract][Full Text] [Related]
10. A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
Huang Z; Zhang L; Zhu D; Shan X; Zhou X; Qi LW; Wu L; Zhu J; Cheng W; Zhang H; Chen Y; Zhu W; Wang T; Liu P
Cancer Med; 2017 Jan; 6(1):109-119. PubMed ID: 28035762
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implication of downregulated exosomal miRNAs in patients with sepsis: a cross-sectional study with bioinformatics analysis.
Shin B; Lee JY; Im Y; Yoo H; Park J; Lee JS; Lee KY; Jeon K
J Intensive Care; 2023 Aug; 11(1):35. PubMed ID: 37537685
[TBL] [Abstract][Full Text] [Related]
12. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
13. RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation.
Wada M; Goto Y; Tanaka T; Okada R; Moriya S; Idichi T; Noda M; Sasaki K; Kita Y; Kurahara H; Maemura K; Natsugoe S; Seki N
J Hum Genet; 2020 Nov; 65(11):1019-1034. PubMed ID: 32623445
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA Derived from Circulating Exosomes as Noninvasive Biomarkers for Diagnosing Renal Cell Carcinoma.
Xiao CT; Lai WJ; Zhu WA; Wang H
Onco Targets Ther; 2020; 13():10765-10774. PubMed ID: 33122915
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
16. Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma.
Butz H; Nofech-Mozes R; Ding Q; Khella HWZ; Szabó PM; Jewett M; Finelli A; Lee J; Ordon M; Stewart R; Krylov S; Yousef GM
Eur Urol Focus; 2016 Jun; 2(2):210-218. PubMed ID: 28723537
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia‑regulated exosomal miR‑185 inhibits esophageal squamous cell carcinoma progression and predicts prognosis.
Maiyulan A; Matsumoto Y; Wang H; Murakami K; Toyozumi T; Otsuka R; Shiraishi T; Kinoshita K; Hu J; Iida S; Morishita H; Makiyama T; Nishioka Y; Kano M; Matsubara H
Oncol Lett; 2024 Jul; 28(1):334. PubMed ID: 38827568
[TBL] [Abstract][Full Text] [Related]
18. Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease.
Zhang P; Liang T; Chen Y; Wang X; Wu T; Xie Z; Luo J; Yu Y; Yu H
Biomed Res Int; 2020; 2020():3593962. PubMed ID: 33381550
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis and microRNA expression profiling of plasma-derived exosomes in primary immune thrombocytopenia.
Sun Y; Hou Y; Meng G; Han P; Zhao Y; Wang H; Xu M; Wang Y; Qiu J; Peng J; Shao L; Sun L; Hou M
Br J Haematol; 2021 Sep; 194(6):1045-1052. PubMed ID: 34337736
[TBL] [Abstract][Full Text] [Related]
20. [Correlations between miRNAs and TGF-β1 in tumor microenvironment of esophageal squamous cell cancer].
Zhu L; Jin L; Jiang R; Wang Q; Jiang J; Mao C; Chen D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 May; 29(5):524-8. PubMed ID: 23643275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
